Introduction {#s01}
============

Microtubules, polymers of α/β tubulin subunits, carry out a wide range of functions in eukaryotes ([@bib5]; [@bib19]). The tubulin gene family expanded substantially in higher eukaryotes, and the expression of different isotypes can vary according to cell identity and stage of development ([@bib15]). For example, flies encode four α and four β tubulin isotypes, whereas humans encode at least seven α and eight β tubulin isotypes that can have distinct expression profiles ([@bib16]). In particular, βII and βIII are the major β tubulins in the brain ([@bib3]), and βVI is limited to the hematopoietic cell lineage ([@bib31]; [@bib12]). Furthermore, recent in vivo studies have revealed that β tubulin isotypes have noninterchangeable roles in development. In *Drosophila melanogaster*, when a testes-specific β tubulin isotype was replaced with a β tubulin isotype not normally expressed in the male germline, axoneme assembly and meiosis were no longer supported ([@bib10]). In mice, embryonic knockdown of neuronal βIII expression led to neural migration defects that could not be rescued by expression of other β tubulin isotypes ([@bib25]). Together, these studies suggest that having multiple tubulin isotypes can be important for achieving diversity in function.

Differences in amino acid sequence of tubulin isotypes can affect two important aspects of tubulin function: the binding to microtubule associated proteins (MAPs) and the dynamics of microtubule polymer assembly. Numerous studies examining MAP interactions have focused on the ∼25 amino acids that comprise the C-terminal tail of tubulin, where many posttranslational modifications are found and where isotype sequence differences are concentrated ([@bib32]; [@bib29]). Thus it has been proposed that tubulin's C-terminal tail may establish a "tubulin code" to direct unique interactions with MAPs ([@bib29]). In contrast, it is unclear whether residue changes in tubulin's C-terminal tail sequence can directly affect microtubule polymerization dynamics. Studies using native tubulin isolated from bovine brain have shown that α/β tubulin dimers with different β isotype composition have distinct polymerization properties ([@bib4]; [@bib14]; [@bib21]), which are partially altered after limited proteolysis by subtilisin ([@bib14]). However, because of challenges in generating human tubulins with modified amino acid sequence from recombinant sources, the basis of the observed changes in polymerization dynamics between tubulin isotypes is still unknown.

Here, we purify recombinant tubulin heterodimers that have human β tubulin isotype IIB (βIIB) and provide the first characterization of its biochemical properties and assembly dynamics. We quantify parameters of dynamic instability and compare them to those of isotype III (βIII) heterodimers that we have recently examined ([@bib27]). Further, we generate chimeric tail-swapped tubulins by fusing the C-terminal tail domain of one isotype to the core of the other and use these proteins to dissect the basis of isotype-specific changes in dynamic instability.

Results and discussion {#s02}
======================

Purification of recombinant α/βIIB tubulin heterodimers {#s03}
-------------------------------------------------------

To determine the biochemical and polymerization properties of human β tubulin isotypes, we purified recombinant tubulin heterodimers using a protocol we have recently developed ([@bib27]). This three-step procedure generated affinity tag--free recombinant protein ([Fig. 1, A--C](#fig1){ref-type="fig"}; and [Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201603050/DC1){#supp1}). We then used mass spectrometry to confirm the presence of human βIIB and showed that heterodimers contained an approximately equimolar mixture of human and insect α tubulins that are ∼97% identical by sequence (Fig. S1 B). Efforts to tag both α and β tubulin with different affinity tags led to a substantially reduced protein yield, and the strategy was not pursued further. We find our multistep approach suitable for comparing tubulins with different β isotype compositions, as done in this study. Hereafter, we refer to the purified recombinant tubulin as α/βIIB, highlighting the specific purified human β tubulin isotype.

![**Purification of recombinant α/βIIB tubulin heterodimers**. (A) Purification scheme. (B) SDS-PAGE analysis (1, lysate; 2, supernatant; 3 and 4, nickel affinity: flow-through (3); elution (4); 5, TEV-digested protein elution from nickel affinity column (a band corresponding to the added TEV protein is at ∼25 kD); 6--8, TOG affinity: flow-through (6); elution (7), 20× amount in lane 7 (8); Coomassie stain). (C) Western blot (WB) analyses. Full blots are provided in [Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201603050/DC1){#supp2}. (D) Elution profiles from size-exclusion chromatography. Peak volume: 14.4 ml (α/βIIB); 14.3 ml (bovine tubulin, used as reference). Void volume (V~0~) is 7 ml. A.U., arbitrary units. (E and F) TIRF images of taxol-stabilized (E) or GMPCPP (F) microtubules. Bars, 3 µm. (G) SDS-PAGE analysis of tubulin sedimentation in the presence of allocolchicine (+Allo) or 3% DMSO control (−Allo). Pellet (P) and supernatant (S) fractions are indicated. (H) Representative equilibrium binding curve for α/βIIB with allocolchicine from one experiment is shown. *K*~d~ = 1.8 ± 0.42 µM (*n* = 3, mean ± SD). [Fig. S1 C](http://www.jcb.org/cgi/content/full/jcb.201603050/DC1){#supp3} shows data averaged from all three experiments and fitted to a single curve.](JCB_201603050_Fig1){#fig1}

We assessed the recombinant α/βIIB tubulin using two approaches. First, size-exclusion chromatography indicated that α/βIIB existed as a stable dimer in solution ([Fig. 1 D](#fig1){ref-type="fig"}) and eluted at a similar volume to bovine tubulin purified using standard methods ([@bib1]; [@bib7]). Second, we examined α/βIIB in the presence of compounds that stabilize or destabilize microtubules. We found that the protein polymerized to form microtubules in the presence of the drug taxol ([Fig. 1 E](#fig1){ref-type="fig"}) and the slowly hydrolyzing GTP analogue, GMPCPP ([Fig. 1 F](#fig1){ref-type="fig"}). Colchicine and related analogues bind soluble tubulin at an interface between the α and β subunits and inhibit tubulin polymerization ([@bib23]). In particular, we examined the binding of our recombinant α/βIIB protein to a colchicine analogue, allocolchicine, which fluoresces only upon binding soluble tubulin and allows for a direct readout of the interaction ([@bib9]; [@bib17]). We first confirmed that allocolchicine can inhibit the assembly of α/βIIB microtubules ([Fig. 1 G](#fig1){ref-type="fig"}). We next determined equilibrium binding and found that α/βIIB tubulin binds allocolchicine with a low-micromolar affinity (*K*~d~ = 1.8 ± 0.42 µM, *n* = 3; [Figs. 1 H](#fig1){ref-type="fig"} and S1 C), similar to that reported for bovine brain tubulin ([@bib24]). Together, these data indicate that our recombinant α/βIIB protein has overall properties similar to those of bovine tubulin purified using conventional methods.

Polymerization properties of recombinant α/βIIB tubulin heterodimers {#s04}
--------------------------------------------------------------------

To analyze polymerization dynamics of recombinant α/βIIB, we used a total internal reflection fluorescence (TIRF)-based single-filament assay ([Fig. 2 A](#fig2){ref-type="fig"}). As a template for microtubule formation, we used GMPCPP-stabilized seeds assembled from α/βIIB tubulin. We then applied solutions of soluble tubulin and observed microtubule assembly off of these seeds over a range of tubulin concentrations ([Fig. 2, B and D](#fig2){ref-type="fig"}). To quantify dynamic instability parameters, we generated kymographs from the time-lapse images of growing microtubules ([Fig. 2, C and E](#fig2){ref-type="fig"}). Even at the lowest tubulin concentration used (6 µM), we observed growth off of all filaments examined. Microtubule elongation occured primarily at only one end of the seed, which we designate the plus end. In contrast, assembly of microtubule polymer was rarely observed off of the minus ends at this concentration and only occasionally observed at the highest concentration used (13 µM); therefore, we did not quantify the polymerization properties of tubulin at the minus end.

![**Single-filament TIRF analysis of α/βIIB tubulin polymerization properties.** (A) TIRF assay schematic. Microtubule extensions (red) and GMPCPP seeds (green) are shown with plus ends (+) and minus ends (−) indicated. TIRF image overlays (B and D) and kymographs (C and E) of microtubule extensions (red) growing from seeds (green; total tubulin: 6 µM \[B and C\] and 13 µM \[D and E\]). (F and G) Plus-end polymerization rates (F) and catastrophe frequencies (G) for microtubules composed of α/βIIB at different total tubulin concentrations. The data were pooled from at least three independent experiments. Overlay images (H--J) and kymographs (K--M) of mixed α/βIIB and α/βIII microtubules (α/βIIB:α/βIII ratio, 3:1 \[H and K\], 1:1 \[I and L\], or 1:3 \[J and M\]; total tubulin, 10.5 µM). (N and O) Plus-end polymerization rate (N) and catastrophe frequency (O) for mixed microtubules (α/βIIB:α/βIII ratio, 1:1, total tubulin, 10.5 µM) with α/βIIB shown for reference. The data were pooled from at least two independent experiments. Bars: (horizontal) 3 µm; (vertical) 2 min. Error bars are SD. For catastrophe frequency (*f~cat~*), SD were calculated as *f~cat~*/$\sqrt{n}$ (assuming a Poisson distribution), where *n* is the number of catastrophe events. [Table 1](#tbl1){ref-type="table"} summarizes these measurements.](JCB_201603050_Fig2){#fig2}

We determined the mean polymerization rate at plus ends of microtubules assembled from α/βIIB tubulin and found that this rate increased with free tubulin concentration ([Fig. 2 F](#fig2){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). The measured growth rates were close to the reported values for α/βIII ([@bib27]) and purified bovine brain tubulin ([@bib30]). We then fitted the data to a simple 1D model ([@bib20]) whose slope and intercept are the apparent association (*k*~+~) and dissociation (*k*~−~) rate constants of tubulin subunits, respectively (*k*~+~ = 1.9 ± 0.5 µM^−1^ s^−1^ and *k*~−~ = 2.6 ± 4.2 s^−1^).

###### Plus end dynamic instability parameters for full-length wild-type tubulins and chimeric tubulins

  Total tubulin concentration and recombinant protein   Polymerization rate (subunit · s^−1^)   Catastrophe frequency (min**^−^**^1^)                   
  ----------------------------------------------------- --------------------------------------- --------------------------------------- --------------- -----
  6 μM                                                                                                                                                  
   α/βIIB                                               9 ± 2                                   70                                      0.06 ± 0.008    60
   α/βIIB-tail-III                                      6 ± 1                                   87                                      0.08 ± 0.008    92
   α/βIII-tail-IIB                                      8 ± 2                                   37                                      0.12 ± 0.02     58
   α/βIII\*                                             8 ± 3                                   77                                      0.10 ± 0.01     105
  10.5 μM                                                                                                                                               
   α/βIIB                                               15 ± 3                                  70                                      0.03 ± 0.006    33
   α/βIIB-tail-III                                      14 ± 3                                  81                                      0.03 ± 0.005    37
   α/βIII-tail-IIB                                      17 ± 2                                  88                                      0.10 ± 0.01     115
   α/βIII\*                                             16 ± 6                                  75                                      0.10 ± 0.01     104
   Mixed (3:1) (α/βIIB:α/βIII)                          ND                                                                              0.05 ± 0.008    41
   Mixed (1:1) (α/βIIB:α/βIII)                          14 ± 2                                  79                                      0.06 ± 0.007    65
   Mixed (1:3) (α/βIIB:α/βIII)                          ND                                                                              0.12 ± 0.009    153
  13 μM                                                                                                                                                 
   α/βIIB                                               25 ± 4                                  52                                      0.03 ± 0.006    20
   α/βIIB-tail-III                                      21 ± 3                                  49                                      0.008 ± 0.003   9
   α/βIII-tail-IIB                                      19 ± 3                                  53                                      0.08 ± 0.01     62
   α/βIII\*                                             19 ± 4                                  57                                      0.09 ± 0.01     68

Measurements are from data presented in [Fig. 2 (F, G, N, and O)](#fig2){ref-type="fig"} and [Fig. 4 (I and J)](#fig4){ref-type="fig"}. Mean ± SD are shown. *n* represents the number of filaments analyzed (for polymerization rate) or catastrophe events (for catastrophe frequency). \*, data from [@bib27]; ND, not determined.

We next measured the frequency of catastrophe, the transition from a state of filament growth to a state of rapid shrinkage. Microtubules assembled from α/βIIB heterodimers underwent a catastrophe event infrequently, and we observed a moderate decrease in catastrophe frequency as tubulin concentration was increased from 6 to 13 µM ([Fig. 2 G](#fig2){ref-type="fig"}). We measured a frequency of 0.03 ± 0.006 min^−1^ at a tubulin concentration close to physiologic levels (10.5 µM). We rarely observed rescue events (the transition from rapid shortening to relatively slow growth) under our experimental conditions and did not analyze this parameter. When we compared our analysis of recombinant α/βIIB tubulin with that of recombinant β tubulin isotype 3 (α/βIII; [@bib27]), we observed key differences. Notably, the catastrophe frequency for α/βIIB was 1.5- to 3-fold lower than that of α/βIII at all tubulin concentrations tested (P \< 0.02 at each concentration; [@bib27]).

Tubulin in cells is a mixture of multiple isotypes of β tubulin. In particular, bovine brain tubulin has been shown to be a mixture of at least four β isotypes (β2, β3, β4, and β1 detected at 58%, 25%, 13%, and 3%, respectively; [@bib3]). Therefore, we mixed α/βIIB and α/βIII heterodimers and analyzed polymerization dynamics ([Fig. 2, H--O](#fig2){ref-type="fig"}). At equal ratios of α/βIIB and α/βIII tubulin (10.5 µM total tubulin), microtubules readily polymerized off of GMPCPP seeds ([Fig. 2 I](#fig2){ref-type="fig"}). The polymerization rate of these mixed microtubules (14 ± 2 subunit ⋅ s^−1^) was close to that of α/βIIB microtubules (15 ± 3 subunit ⋅ s^−1^; [Fig. 2 N](#fig2){ref-type="fig"}) and α/βIII microtubules ([@bib27]) at the same tubulin concentration. This suggests that the two isotypes can indeed copolymerize. If they did not, the expected polymerization rate would be ∼7--8 subunit ⋅ s^−1^, as the effective concentration would be 5.25 µM for each isotype. The catastrophe frequency at filament plus ends was 0.06 ± 0.01 min^−1^ at 10.5 µM total tubulin concentration ([Fig. 2 O](#fig2){ref-type="fig"}). This value is intermediate between that for α/βIIB microtubules (0.03 ± 0.01 min^−1^; [Fig. 2 G](#fig2){ref-type="fig"}) and that for α/βIII microtubules ([@bib27]). Together, our data indicate that the dynamics of microtubules assembled from mixed tubulin populations depends on the contribution of each isotype, and that mixing gives a catastrophe frequency intermediate between what is observed for either isotype alone.

Characterization of recombinant tubulins containing human β tubulin chimeras {#s05}
----------------------------------------------------------------------------

To examine whether residue changes within tubulin's C-terminal tail, which are proposed to specify interactions with MAPs ([@bib26]), also confer the observed isotype-specific catastrophe frequencies, we generated chimeric β tubulin constructs with the C-terminal tails swapped ([Fig. 3 A](#fig3){ref-type="fig"}). We designated the core region (aa 1--427) to be equal to the length of tubulin protein resolved in a recent structural study ([@bib2]), and the tail region to be the remaining C-terminal amino acids (aa 428--445 in βIIB and 428--450 in βIII). We coexpressed one of the two chimeric β tubulins fused to a cleavable hexahistidine tag along with human α isotype 1B in insect cells and generated the following two heterodimers: α/βIIB-tail-III (βIIB core and βIII tail) and α/βIII-tail-IIB (βIII core with βIIB tail; [Fig. 3 B](#fig3){ref-type="fig"}).

![**Design and characterization of chimeric β tubulin constructs.** (A) Design of tail-swapped β tubulin constructs, with amino acid sequence derived from α/βIIB (black) and α/βIII (gray). (B) Schematic of tubulin heterodimer indicating β tubulin C-terminal tail (black). Amino acid sequences from the C terminus of βIIB and βIII are shown. (C) SDS-PAGE analysis (1, nickel affinity elution; 2, TOG affinity elution; Coomassie stain). (D) Western blot (WB) analysis. Full blots are provided in [Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201603050/DC1){#supp4}. (E) Protein elution profiles from size-exclusion chromatography. Peak volume: 14.2 ml (α/βIIB-tail-III); 14.1 ml (α/βIII-tail-IIB). Void volume (V~0~) is 7 ml. A.U., arbitrary units. (F and G) TIRF images of taxol-stabilized (F) or GMPCPP (G) microtubules. Bars, 3 µm.](JCB_201603050_Fig3){#fig3}

Using our purification protocol, we generated affinity tag--free recombinant chimeric tubulin heterodimers ([Fig. 3, C and D](#fig3){ref-type="fig"}; and [Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201603050/DC1){#supp5}) that were of similar purity to that of α/βIIB. Size-exclusion chromatography analysis indicated that the α/βIIB-tail-III and α/βIII-tail-IIB proteins existed as stable dimers in solution and eluted at a volume similar to the full-length α/βIIB ([Figs. 3 E](#fig3){ref-type="fig"} and [1 D](#fig1){ref-type="fig"}). As with the full-length α/βIIB tubulin, we analyzed the chimeric proteins using a TIRF microscopy--based assay. We showed that both chimeric tubulins assembled readily into microtubules in the presence of taxol ([Fig. 3 F](#fig3){ref-type="fig"}) and GMPCPP ([Fig. 3 G](#fig3){ref-type="fig"}). These experiments indicated that the chimeric tubulins formed stable dimers and polymerized under standard conditions.

Polymerization properties of recombinant tubulins containing β tubulin chimeras {#s06}
-------------------------------------------------------------------------------

To determine the intrinsic dynamic properties of recombinant tubulin heterodimers containing chimeric β tubulins, we used the same single-filament TIRF assays used to analyze the full-length α/βIIB construct ([Fig. 2 A](#fig2){ref-type="fig"}). We first used GMPCPP-stabilized seeds assembled from α/βIIB-tail-III and applied solutions composed of different concentrations of α/βIIB-tail-III onto the seeds. In separate experiments, we examined growth of α/βIII-tail-IIB tubulin off of α/βIII-tail-IIB seeds.

In the case of α/βIIB-tail-III tubulin, we frequently observed growth at only one of the two ends of the seed ([Fig. 4, A--D](#fig4){ref-type="fig"}), as was noted for full-length α/βIIB. At the plus ends, the rate of polymerization for microtubules assembled from α/βIIB-tail-III increased with greater concentrations of free tubulin ([Fig. 4 I](#fig4){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). The apparent *k*~+~ (2.0 ± 0.4 µM^−1^ s^−1^) and *k*~−~ (5.5 ± 2.7 s^−1^) for α/βIIB-tail-III were close to those measured for α/βIIB and α/βIII ([@bib27]).

![**Single-filament TIRF analysis of chimeric β tubulins.** TIRF image overlays (A, C, E, and G) and kymographs (B, D, F, and H) showing microtubule extensions (red) growing from GMPCPP seeds (green) assembled with α/βIIB-tail-III (A--D) or α/βIII-tail-IIB (E--H). (I and J) Plus-end polymerization rates (I) and catastrophe frequencies (J) for chimeric α/βIIB-tail-III or α/βIII-tail-IIB microtubules at different free tubulin concentrations. Catastrophe frequency measurements for full-length α/βIIB (blue dashed line) and α/βIII (red dashed line) are shown for reference. The data were pooled from at least three independent experiments. Error bars are SD. For catastrophe frequency (*f~cat~*), SD were calculated as *f~cat~*/$\sqrt{n}$ (assuming a Poisson distribution), where *n* is the number of catastrophe events. Bars: (horizontal) 3 µm; (vertical) 2 min. [Table 1](#tbl1){ref-type="table"} summarizes these measurements.](JCB_201603050_Fig4){#fig4}

In contrast, in a solution of α/βIII-tail-IIB tubulin, assembly frequently occurred off both ends of seeds at all tubulin concentrations ([Fig. 4, E--H](#fig4){ref-type="fig"}). This was consistent with what we found for full-length recombinant α/βIII, which grows frequently at both seed ends under similar experimental conditions ([@bib27]). To compare rates between isotypes, we focused on the faster-growing plus end. The polymerization rate of microtubules assembled from α/βIII-tail-IIB tubulin also increased with increasing concentrations of free tubulin ([Fig. 4 I](#fig4){ref-type="fig"}). The apparent *k*~+~ (1.8 ± 0.5 µM^−1^ s^−1^) and *k*~-~ (2.4 ± 4.2 s^−1^) for α/βIII-tail-IIB were close to those of both full-length α/βIIB and full-length α/βIII. These data indicate that each of the chimeric β tubulin constructs can elongate into microtubule polymer at rates close to those measured for each of the full-length wild-type proteins α/βIIB and α/βIII.

We next analyzed catastrophe frequency, the dynamic instability parameter that differs between α/βIIB and α/βIII. For α/βIIB-tail-III microtubules, the catastrophe frequencies were close to those of the full-length α/βIIB at the same tubulin concentrations ([Fig. 4 J](#fig4){ref-type="fig"} and [Fig. 2 G](#fig2){ref-type="fig"}). Next, we measured the catastrophe frequencies of microtubules assembled from α/βIII-tail-IIB tubulin and found them to be ∼1.5- to 3-fold higher than those of α/βIIB-tail-III microtubules over a range of tubulin concentrations ([Fig. 4 J](#fig4){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). These catastrophe frequencies of α/βIII-tail-IIB microtubules were close to the reported catastrophe frequencies of microtubules assembled from full-length α/βIII ([Fig. 4 J](#fig4){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). Together, these data indicate that the amino acid substitutions within the structured core are crucial for establishing isotype-specific parameters of dynamic instability.

Our studies indicate that microtubules assembled from each of the two tubulin isotypes can have substantially different catastrophe frequencies. The suppression of catastrophe in α/βIIB microtubules observed in vitro is on the order of what can be achieved by regulatory proteins in cells, such as TPX2, and by microtubule-stabilizing drugs, such as taxol ([@bib18]; [@bib34]). Human tubulins βIIB and βIII differ in amino acid identity at ∼9% of residues within the ∼450-aa polypeptide, and the short ∼25-residue C-terminal tail carries a large fraction (15 of 42) of the total residue changes ([Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.201603050/DC1){#supp6}). Our analyses of chimeric tail-swapped tubulins suggest that of these 42 nonidentical residues, those within the structured core of tubulin are largely responsible for the different dynamics. Recent studies examining the effects of residue mutations in tubulin's intermediate domain ([@bib8]) and kinesin-binding site ([@bib27]) are beginning to reveal how subtle allostery within the tubulin heterodimer affects microtubule assembly dynamics. Given that there are 27 amino acid differences between the βIIB and βIII isotypes within the tubulin core, and that each may affect long-range communication across the dimer, structure or sequence alone is not likely to help prioritize which residues should be examined. Additional studies will be needed to identify which of the 27 amino acid differences, alone or in combination with other residues, specify the observed differences in dynamic instability. Studies in *Drosophila* have revealed how the exogenous expression of tubulin isotypes from another insect species can alter microtubule protofilament number in cells ([@bib22]). Our recombinant expression system will help dissect whether these effects are caused by intrinsic properties of tubulin isotypes and whether differences in protofilament number can also regulate dynamic instability.

There are five β tubulins expressed in the brain ([@bib3]; [@bib11]). The core sequence of βIIB shares the least amount of similarity with that of βIII compared with the other isotypes expressed in the tissue ([@bib11]; Fig. S2 B). We hypothesize that these two tubulin isotypes establish the range of potential catastrophe frequencies of neuronal microtubules. In addition, our data indicate that recombinant α/βIIB and α/βIII tubulin can copolymerize and form microtubules comprising mixed isotypes, which have catastrophe frequencies intermediate between those measured for microtubules composed of either β tubulin isotype alone. Based on intrinsic polymerization properties alone and a simple model ([@bib28]), the mean length of microtubules assembled from α/βIIB would be approximately three times longer than those assembled from α/βIII (see Materials and methods), and the mean length of mixed microtubules would be intermediate. Thus, microtubule dynamics could be tuned to have different catastrophe frequencies by varying the ratio of different isotypes in cells. Additional functional specialization would come through interactions with MAPs and via posttranslational modifications.

Materials and methods {#s07}
=====================

Purification of recombinant human tubulin {#s08}
-----------------------------------------

The cDNA encoding *Homo sapiens* α tubulin 1B ([NP_006073.2](NP_006073.2)) and β tubulin 2B ([BC001352](BC001352)) were cloned into pFastBac Dual vector (Thermo Fisher Scientific). For affinity purification, a sequence encoding a Tobacco Etch virus (TEV) protease site and hexahistidine tag was fused to the 3′ end of the β tubulin isotype 2B cDNA sequence. We used the Bac-to-Bac system (Thermo Fisher Scientific) to generate recombinant baculovirus. HiveFive cells (Thermo Fisher Scientific), grown to 3.0--3.5 × 10^6^ cells/ml in Sf-900 II SFM (10902-096; Thermo Fisher Scientific) and supplemented with 1× antibiotic-antimyocotic (15240-062; Thermo Fisher Scientific), were infected with P3 viral stocks. Cells were cultured in suspension at 27°C and harvested 60 h after infection. The following steps were performed on ice or at 4°C. We lysed cells in an equal volume of lysis buffer (50 mM Hepes, 20 mM imidazole, 100 mM KCl, 1 mM MgCl~2~, 0.5 mM DTT, 0.1 mM GTP, 3 U/ml benzonase, and 1× protease inhibitor Roche Complete EDTA-free, pH 7.2) by dounce homogenizer (20 strokes) and centrifuged the homogenate at 55,000 rpm in a rotor (Ti70; Beckman Coulter) for 1 h. The supernatant was then filtered through a 0.22-µm Millex-GP PES membrane (SLGP033RS; EMD Millipore) and loaded at 0.8 ml/min onto a 1-ml HisTrap HP column (17-5247-01; GE Healthcare) preequilibrated with lysis buffer. The column was washed with 25 ml lysis buffer and then eluted with nickel elution buffer (1× BRB80 \[80 mM Pipes, 1 mM MgCl~2~, and 1 mM EGTA\], 500 mM imidazole, 0.1 mM GTP, and 1 mM DTT, pH 6.8). The fractions containing proteins were pooled, diluted 10-fold with TOG-column buffer (1× BRB80, 1 mM DTT, and 0.2 mM GTP, pH 6.8), mixed with 6 mg TEV protease, and incubated for 1 h on ice. The TEV-digested protein solution was loaded at 1 ml/min onto tandem chromatography columns consisting of a 1-ml HiTrap SP Sepharose FF column (17-5054-01; GE Healthcare) and a 1-ml TOG-affinity column ([@bib33]) containing TOG 1 and 2 domains. The columns were then washed with 10 ml TOG column buffer. We removed the 1-ml HiTrap SP Sepharose FF column and washed the 1-ml TOG-affinity column with 20 ml wash buffer 1 (1× BRB80, 1 mM DTT, 0.1 mM GTP, 10 mM MgCl~2~, and 5 mM ATP, pH 6.8), 20 ml wash buffer 2 (1× BRB80, 1 mM DTT, 0.1 mM GTP, 0.1% Tween-20, and 10% glycerol, pH 6.8), and 10 ml TOG column buffer. The tubulin was eluted with TOG elution buffer (1× BRB80, 500 mM (NH~4~)~2~SO~4~, 1 mM DTT, and 0.2 mM GTP, pH 6.8). The eluate containing tubulin was pooled, exchanged into storage buffer (1× BRB80, 5% glycerol, 1 mM DTT, and 0.2 mM GTP, pH 6.8), and concentrated to at least 3 mg/ml with an Amicon Ultra 50K MWCO centrifugal filter (UFC901024; EMD Millipore) within 2 h after elution from the TOG column. A typical preparation yielded 1.5 mg protein from 1 liter of cultured insect cells. The purified tubulin was snap-frozen with liquid nitrogen and stored at −80°C.

Mass spectrometry analysis {#s09}
--------------------------

Mass spectrometry was performed essentially as described previously ([@bib13]). Dried protein samples were resuspended in LDS sample buffer (Thermo Fisher Scientific), reduced, alkylated, and separated on a 4--12% Bis-Tris gradient gel (Thermo Fisher Scientific), followed by in-gel trypsin digestion. Tryptic peptides were purified and analyzed on an LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific). To quantify the relative amounts of human and insect α tubulin in the final protein, we compared the signal intensities for each pair of unique peptides that differed by no more than one amino acid and took the mean for all of the peptide pairs. To examine the possibility of insect β tubulin copurifying in our final protein, we used a similar approach. Insect β tubulin was detected at low abundance, indicating that it is not a major contaminant of our final recombinant protein. We estimate this fraction of insect tubulin to constitute ∼4% of the total β tubulin.

Microtubule sedimentation assay in the presence of allocolchicine {#s10}
-----------------------------------------------------------------

Allocolchicine was synthesized by the established method ([@bib6]). Purified tubulin was preclarified by high-speed centrifugation in a TLA120.1 rotor (Beckman Coulter) at 90,000 rpm for 10 min at 4°C. Solutions of preclarified tubulin (13 µM) were prepared in assay buffer (1× BRB80, 33.33% \[vol/vol\] glycerol, 1 mM GTP, and 1 mM *tris*(2-carboxyethyl)phosphine \[TCEP\]) containing 3% DMSO and 60 µM allocolchicine or 3% DMSO alone. The reactions were incubated at RT for 30 min, followed by another 30-min incubation at 37°C, and then subjected to high-speed centrifugation in a TLA 120.1 rotor (Beckman Coulter) at 90,000 rpm for 10 min at 30°C. The supernatant was removed and saved for SDS-PAGE analysis. The pellet was rinsed with 40 µl warm wash buffer (1× BRB80, 60% \[vol/vol\] glycerol, and 1 mM TCEP) and resuspended in 1× Laemmli sample buffer for SDS-PAGE analysis.

Binding of allocolchicine to tubulin {#s11}
------------------------------------

Purified tubulin was preclarified by high-speed centrifugation in a TLA120.1 rotor (Beckman Coulter) at 90,000 rpm for 10 min at 4°C. Preclarified tubulin (3 µM) was mixed with increasing concentrations of allocolchicine (0, 1.3, 2.6, 3.9, 5.2, 7.8, 15.6, 31.2, or 62.4 µM) in assay buffer (1× BRB80, 5% \[vol/vol\] glycerol, 1 mM GTP, and 1 mM TCEP). After 2 h of incubation at RT, the emission spectra of the reactions were collected from 360 to 420 nm with 5-nm increments using excitation at 310 nm. The measured fluorescence intensity at 400 nm was plotted on the vertical axis versus allocolchicine concentration on the horizontal axis. To determine the affinity of tubulin for allocolchicine, the unnormalized equilibrium binding curves were fitted with the following equation:$$\begin{array}{l}
{{Fluorescence~intensity~at~}400{~nm} =} \\
\frac{\left( K_{d} + \left\lbrack Allo \right\rbrack + \left\lbrack {Tubulin} \right\rbrack \right) - \sqrt{\left( K_{d} + \left\lbrack Allo \right\rbrack + \left\lbrack Tubulin \right\rbrack \right)^{2}~ - 4 \times \left\lbrack Allo \right\rbrack \times \left\lbrack Tubulin \right\rbrack}}{2 \times \left\lbrack {Tubulin} \right\rbrack} \\
{\times \left( F_{max} - F_{Background} \right) + F_{Background},} \\
\end{array}$$where *K*~d~ represents the dissociation constant for allocolchicine binding, *F~max~* represents the fluorescence intensity at plateau, and *F~background~* represents the fluorescence intensity of tubulin (62.4 μM) in the absense of allocolchicine.

In vitro fluorescence microscopy {#s12}
--------------------------------

All experiments were performed on an Eclipse Ti microscope (Nikon) equipped with a NA 1.49 100× Plan Apo TIRF objective (Nikon). The microscope setup included a three-axis piezo-electric stage (Nano LP-200; Mad City Labs), an EM-CCD camera (iXon DU-897; Andor Technology), and two-color TIRF imaging optics (lasers: 488 nm \[Spectra-Physics\] and 561 nm \[Cobalt\]; filters: emission \[FF01-520/35 and FF01-609/54; Semrock\], dichroic \[Di01-R488/561; Semrock\]). Sample chambers were prepared by first cleaning 18 × 18-mm glass coverslips (thickness no. 1; Gold Seal Cover Glass) and 27 × 46-mm slides (40-80000-01; Buehler). To prevent nonspecific surface sticking, we then coated the surface of slides with nonbiotinylated PEG and the surface of coverslips with a mixture of biotinylated PEG and nonbiotinylated PEG according to standard protocols. To build flow chambers, we applied two strips of double-sided tape to a microscope slide and applied the coverslip. Sample chamber volumes were ∼6--8 µl.

To generate seeds for templated microtubule growth, we polymerized the recombinant tubulins at 12-µM concentration along with 8 mol% Alexa Fluor 488 and biotin-labeled bovine tubulin in the presence of 2.5 mM GMPCPP. The polymerized GMPCPP seeds were immobilized on a coverslip by first coating the surface with NeutrAvidin. After a brief incubation with κ-casein to block nonspecific binding to the surface, a mixture of recombinant tubulin and 4 mol% X-rhodamine--labeled bovine tubulin was flowed into the TIRF chamber maintained at 30°C. Time-lapse images were acquired at a rate of one frame every 10 s for 15 min. All assays with dynamic microtubules were done in buffer containing 1× BRB80, 1 mM GTP, 4% glycerol, 0.2 mg/ml κ-casein, 0.2% methylcellulose, and oxygen scavenging mix (25 mM glucose, 40 mg/ml glucose oxidase, 35 mg/ml catalase, and 0.5% β-mercaptoethanol final concentration in reaction).

Image analysis was performed by creating kymographs from the time-lapse TIRF images of microtubules using ImageJ. The data were quantified by measuring the slope of the growing microtubule extension and using it to determine the mean growth speed for each filament. The mean polymerization rate was calculated from all microtubules analyzed for each condition. The mean and standard deviation are reported in the figures. To determine catastrophe frequency, we divided the total number of catastrophe events for all filaments by the total polymerization time (the sum of the time each GMPCPP seed was observed with a growing microtubule extension). The standard deviation was estimated as the catastrophe frequency divided by the square root of the number of catastrophe events. This assumes that catastrophe events are Poisson processes.

Estimating the mean length of microtubules {#s13}
------------------------------------------

We used a model that described the probability of finding a microtubule of a given length *x* at any time, assuming four dynamic instability parameters: *v~g~* (velocity of growth), *v~s~* (velocity of shrinkage), *f~cat~* (frequency of catastrophe), and *f~res~* (frequency of rescue; [@bib28]).

The length probability distribution can be described as$$p\left( x \right) = \frac{1}{L} \times e^{- ~\frac{x}{L}}$$From their derivations, the average length *L* is estimated by$$L = \frac{v_{s}v_{g}}{\left( v_{s}f_{cat} \right) - \left( v_{g}f_{res} \right)}$$We make the simplifying assumption that *f~res~* = 0; as we rarely observe rescue events. So this simplifies to$$L = \frac{v_{s}v_{g}}{v_{s}f_{cat}} = \frac{v_{g}}{f_{cat}}$$At 10.5-µM tubulin concentration, the growth rates of α/βIIB microtubules and α/βIII microtubules are approximately equal and the catastrophe frequencies are such that$$f_{cat\_\alpha/\beta{IIB}} = \frac{1}{3}f_{cat\_\alpha/\beta{III}}$$This implies that the length of α/βIIB microtubules would be approximately threefold greater than that of α/βIII microtubules.

Online supplemental material {#s14}
----------------------------

Fig. S1 shows the purification of recombinant α/βIIB tubulin heterodimers. Fig. S2 shows the purification of chimeric β tubulin heterodimers and tubulin isotype identity matrix. Fig. S3 shows β tubulin isotypes IIB and III alignment and a secondary structure topology map. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201603050/DC1>.
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